Richard F. Riedel

Also affiliated with University Hospital Heidelberg, Dana-Farber Cancer Institute, Duke Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Atezolizumab for Advanced Alveolar Soft Part Sarcoma”.

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

New England Journal of Medicine(2023)10.1056/nejmoa2303383

N/A

3.3DataRank · unranked

158 citations

Elad Sharon, Geraldine O’Sullivan Coyne, Nancy Moore, Jared C. Foster, James Hu +26 more

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11519

N/A

1.8DataRank · unranked

50 citations

Geraldine O’Sullivan Coyne, Nancy Moore, Elad Sharon, Naoko Takebe, Kristin Fino +15 more

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma

Journal of Clinical Oncology(2024)10.1200/jco.24.00020

N/A

0.869DataRank · unranked

38 citations

Noah Federman, Najat C. Daw, Peter M. Anderson, Lara E. Davis, AeRang Kim +9 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Evolving strategies for management of desmoid tumor

Cancer(2022)10.1002/cncr.34332

N/A

0.657DataRank · unranked

79 citations

Mark Agulnik, Richard F. Riedel

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0.542DataRank · unranked

36 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0.477DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

UNC Libraries(2020)10.17615/jcyr-9v75

N/A

0.442DataRank · unranked

18 citations

Candace Shelton, Matthew Meyerson, Carrie Cibulskis, Jia Liu, Joshua Armenia +95 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11562

N/A

0DataRank · unranked

7 citations

Michelle R. Mahoney, Fabrizio Remotti, Ardaman Shergill, Mark A. Dickson, Richard F. Riedel +10 more